AN EVALUATION OF THE SAFETY AND EFFICACY OF FLUCONAZOLE IN THE TREATMENT OF ONYCHOMYCOSIS

被引:30
|
作者
SMITH, SW [1 ]
SEALY, DP [1 ]
SCHNEIDER, E [1 ]
LACKLAND, D [1 ]
机构
[1] SELF MEM HOSP,MONTGOMERY CTR FAMILY MED,GREENWOOD,SC 29646
关键词
D O I
10.1097/00007611-199512000-00006
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Sixteen subjects were enrolled in this open-label noncomparative study to evaluate the safety and efficacy of fluconazole as a single daily dose for a period of 6 months. Liver function enzymes were monitored to assess safety. An adverse reaction questionnaire was used on a monthly basis to assess patient tolerance. A visual analogue scale was used to assess efficacy of treatment. After 6 months of fluconazole, all subjects experienced improvement in the appearance of their nails. None of the subjects evidenced any elevation in liver function enzymes. Adverse reactions were limited and consistent with other studies involving fluconazole. Fluconazole proved to be safe and efficacious in the treatment of onychomycosis. Further studies are needed to determine a cost-effective dosing regimen for the treatment of onychomycosis with fluconazole.
引用
收藏
页码:1217 / 1220
页数:4
相关论文
共 50 条
  • [41] Efficacy and safety of a single oral 150 mg dose of fluconazole for the treatment of vulvovaginal candidiasis in Japan
    Mikamo, Hiroshige
    Matsumizu, Miyako
    Nakazuru, Yoshiomi
    Okayama, Akifumi
    Nagashima, Masahito
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2015, 21 (07) : 520 - 526
  • [42] Efficacy and Safety of Onychomycosis Treatments: An Evidence-Based Overview
    Pariser, David M.
    Jellinek, Nathaniel J.
    Rich, Phoebe
    SEMINARS IN CUTANEOUS MEDICINE AND SURGERY, 2015, 34 : S46 - S50
  • [43] Efficacy and safety of a new medicated nail hydrolacquer in the treatment of adults with toenail onychomycosis: A randomised clinical trial
    Zalacain-Vicuna, Antonio J.
    Nieto, Carlos
    Picas, Jordi
    Martinez, Helena
    Bermejo, Rafael
    Corrales, Adrian
    Fernandez Campos, Francisco
    Anguiano Igea, Soledad
    Javier Otero-Espinar, Francisco
    Garcia-Patos Briones, Vicente
    MYCOSES, 2023, 66 (07) : 566 - 575
  • [44] Age as limiting factor of the efficacy of itraconazole for treatment of onychomycosis
    Fiallo, P
    Cardo, PP
    MYCOSES, 2001, 44 (05) : 191 - 194
  • [45] Preliminary Evidence of the Efficacy of Nitric Acid Treatment in Onychomycosis
    Marcos-Tejedor, Felix
    Santos-Carnicero, Natividad
    Mayordomo, Raquel
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2021, 18 (24)
  • [46] Continuous itraconazole treatment for onychomycosis and dermatomycosis: an overview of safety
    Nolting, SK
    Gupta, A
    De Doncker, P
    Jacko, ML
    Moskovitz, BL
    EUROPEAN JOURNAL OF DERMATOLOGY, 1999, 9 (07) : 540 - 543
  • [47] Evaluation of safety and efficacy of the TriPollar technology for treatment of wrinkles
    Shapiro, Steven D.
    Eros, Yoav
    Abrahami, Yoav
    Leviav, Amos
    LASERS IN SURGERY AND MEDICINE, 2012, 44 (06) : 453 - 458
  • [48] Evaluation of efficacy and safety of flunisolide hydrofluoroalkane for the treatment of asthma
    Corren, J
    Tashkin, DR
    CLINICAL THERAPEUTICS, 2003, 25 (03) : 776 - 798
  • [49] An Evaluation of the Efficacy and Safety of Vibegron in the Treatment of Overactive Bladder
    Frankel, Jeffrey
    Staskin, David
    Varano, Susann
    Kennelly, Michael J.
    Jankowich, Rachael A.
    Haag-Molkenteller, Cornelia
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2022, 18 : 171 - 182
  • [50] Evaluation of the efficacy and safety of etoricoxib in the treatment of hemophilic arthropathy
    Tsoukas, C
    Eyster, ME
    Shingo, S
    Mukhopadhyay, S
    Giallella, KM
    Curtis, SP
    Reicin, AS
    Melian, A
    BLOOD, 2006, 107 (05) : 1785 - 1790